Savara Pharmaceuticals
SVRA
#6890
Rank
โ‚น41.18 B
Marketcap
โ‚น239.95
Share price
6.15%
Change (1 day)
-40.76%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -โ‚น22.99

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -โ‚น24.34. In 2022 the company made an earnings per share (EPS) of -โ‚น21.73 an increase over its 2021 EPS that were of -โ‚น29.56.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น22.995.77%
2022-โ‚น21.73-26.47%
2021-โ‚น29.56-59.52%
2020-โ‚น73.03-56.48%
2019-โ‚น167.792.66%
2018-โ‚น163.45-38.56%
2017-โ‚น266.03-71.06%
2016-โ‚น919.31-37.06%
2015-โ‚น1,4614.35%
2014-โ‚น1,400-25.81%
2013-โ‚น1,887-8.82%
2012-โ‚น2,069-27.66%
2011-โ‚น2,860-58.41%
2010-โ‚น6,877-86%
2009-โ‚น49,1114.13%
2008-โ‚น47,16324%
2007-โ‚น38,035-35.9%
2006-โ‚น59,33595%
2005-โ‚น30,42853.85%
2004-โ‚น19,77844.44%
2003-โ‚น13,693-40%
2002-โ‚น22,821

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-โ‚น86.94 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น23.47-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA